Nocebo

Additional recommended knowledge How to ensure accurate weighing results every day? Safe Weighing Range Ensures Accurate Results Weighing the right way Contents 1 The term "nocebo" 2 The nocebo effect 3 The nocebo response 4 Why a nocebo response? 5 Ambiguity of medical usage 6 Ambiguity of anthropological usage 7 See also 8 Notes 9 References

In its original application, "nocebo" had a very specific meaning in the medical domains of pharmacology, and nosology, and aetiology.

It was a subject-oriented adjective that was used to label the harmful, unpleasant, or undesirable reactions (or responses) that a subject manifested (thus, "nocebo reactions" or "nocebo responses") as a result of administering an inert dummy drug, where these responses had not been chemically generated, and were entirely due to the subject's pessimistic belief and expectation that the inert drug would produce harmful, injurious, unpleasant, or undesirable consequences.

In these cases, there is no "real" drug involved, but the actual harmful, unpleasant or undesirable biochemical, physiological, behavioural, emotional, and/or cognitive consequences of the administration of the inert drug are very real. One known example is dying of fright after being bitten by a non-poisonous snake.

The term "nocebo"

The term nocebo (Latin for "I will harm") was chosen by Walter Kennedy, in 1961, to denote the counterpart of one of the more recent applications of the term "placebo" (= "I will please"); namely, that of a placebo being a drug that produced a beneficial, healthy, pleasant, or desirable consequence in a subject, as a direct result of that subject's beliefs and expectations.

Today, in the same way that the term placebo (or "placebo drug") is often used wrongly in an agent-oriented way to denote an active drug that produces an entirely predictable, and intentionally sought after outcome that is experienced as pleasant or desirable (e.g., analgesia), the term nocebo (or nocebo drug) is often used wrongly to denote its counterpart, an active drug that produces an entirely predictable, and intentionally sought outcome that is experienced as unpleasant or undesirable (e.g., nausea).^{[citation needed]}

Houston may have been the first to have spoken of a doctor's deliberate application of harmful "placebo" procedures, as distinct from the other, harmless sort of "placebo" procedures a doctor might apply and whose "usefulness was in direct proportion to the faith that the doctor had and the faith that he was able to inspire in his patients". Houston (1938,p.1418) wrote:

... [and while the efficacy of the placebo procedure] is believed in by the doctor, [the placebo procedure itself] is no longer harmless but harmful, sometimes very dangerous. It would seem peculiarly contradictory to speak of the painful and dangerous placebo, yet men are so constituted that they feel the need in dire extremity of resorting to dread measures. Nervous patients in particular, feel that a certain standing and sanction is bestowed upon their maladies when violent therapeutic measures are used."

Houston spoke of three significantly different categories of placebo (pp.1417-1418):

• the drug that the physician knows to be inert, but which the subject believes to be potent.
• the drug which is believed to be potent by both subject and physician, but which later investigation proves to have been totally inert.
• the drug which is believed to be potent by both subject and physician, but is actually harmful and dangerous, rather than being inert and harmless.

The term "nocebo response" originally only meant an unpredictable unintentional belief-generated injurious response to an inert procedure.

But there is an emerging practice of labelling drugs that produce unpleasant consequences as "nocebo drugs" meaning that the term "nocebo response" may be being used to label an intentional, entirely pharmacologically-generated and quite predictably injurious outcome that has ensued from the administration of an active (nocebo) drug.

Anthropologists use the term "nocebo ritual" to describe a procedure, treatment, or ritual that has been performed (or a herbal remedy or medication that has been administered) with malicious intent, by contrast with a placebo procedure or treatment or ritual that is performed with a benevolent intent.

The nocebo effect

Because the original meaning of "nocebo" specifically referred to a subject's response to an inert drug, the term nocebo effect can really only refer to the consequences of the application of a "harm-producing" "nocebo drug" (however, the concept of a "harm-producing" "nocebo drug" is a much later concept than either that of a "nocebo response" or of a "nocebo reaction").

The nocebo response

In the strictest sense, a nocebo response is where a drug-trial's subject's symptoms are worsened by the administration of an inert, sham,^[1] or dummy (simulator) treatment, called a placebo.

According to current pharmacological knowledge and the current understanding of cause and effect, a placebo contains no chemical (or any other agent) that could possibly cause any of the observed worsening in the subject's symptoms. Thus, any change for the worse must be due to some subject-internal factor.

The worsening of the subject's symptoms is a direct consequence of their exposure to the placebo, but those symptoms have not been chemically generated by the placebo. Because this generation of symptoms entails a complex of "subject-internal" activities, in the strictest sense, we can never speak in terms of simulator-centred "nocebo effects", but only in terms of subject-centred "nocebo responses".

Although some attribute nocebo responses (or placebo responses) to a subject's gullibility, there is no evidence that an individual who manifests a nocebo/placebo response to one treatment will manifest a nocebo/placebo response to any other treatment; i.e., there is no fixed nocebo/placebo-responding trait or propensity.

McGlashan, Evans & Orne (1969, p.319) found no evidence of what they termed a "placebo personality". Also, in a carefully designed study, Lasagna, Mosteller, von Felsinger & Beecher (1954), found that there was no way that any observer could determine, by testing or by interview, which subject would manifest a placebo reaction and which would not.

Experiments have shown that no relationship exists between an individual's measured hypnotic susceptibility and his/her manifestation of nocebo or placebo responses.^[2]

Why a nocebo response?

The term "nocebo response" was coined in 1961 by Walter Kennedy (he actually spoke of a "nocebo reaction").

He had observed that another, entirely different and unrelated, and far more recent meaning of the term placebo was emerging into far more common usage in the technical literature (see homonym); namely that a "placebo response" (or "placebo reaction") was a "pleasant" response to a real or sham/dummy treatment (this new and entirely different usage was based on the Latin meaning of the word placebo, "I shall please").

Kennedy chose the Latin word nocebo ("I shall harm") because it was the opposite of the Latin word placebo ("I shall please"), and used it to denote the counterpart of the placebo response: namely, an "unpleasant" response to the application of real or sham treatment.

Kennedy very strongly emphasized that his specific usage of the term nocebo did not refer to "the iatrogenic action of drugs":^[3] in other words, according to Kennedy, there was no such thing as a "nocebo effect", there was only a "nocebo response".

He insisted that a nocebo reaction was subject-centred, and he was emphatic that the term nocebo reaction specifically referred to "a quality inherent in the patient rather than in the remedy".^[3]

Even more significantly, Kennedy also stated that whilst "nocebo reactions do occur [they should never be confused] with true pharmaceutical effects, such as the ringing in the ears caused by quinine".^[3]

This is strong, clear and very persuasive evidence that Kennedy was precisely speaking of an outcome that had been totally generated by a subject's negative expectation of a drug or ritual's administration; which was the exact counterpart of a placebo response that would have been generated by a subject's positive expectation.

And, finally, and most definitely, Kennedy was not speaking of an active drug's unwanted, but pharmacologically predictable negative side-effects (something for which the term nocebo is being increasingly used in current literature).

Ambiguity of medical usage

In an important recent paper,^[4] Stewart-Williams and Podd argue that using the contrasting terms "placebo" and "nocebo" to label inert agents that produce pleasant, health-improving or desirable outcomes, or unpleasant, health-diminishing, or undesirable outcomes (respectively), is extremely counterproductive.

For example, precisely the same inert agents can produce analgesia and hyperalgesia, the first of which, from this definition, would be a placebo, and the second a nocebo.

A second problem is that precisely the same effect, such as immunosuppression, may be quite desirable for a subject with an autoimmune disorder, but be quite undesirable for most other subjects. Thus, in the first case, the effect would be a placebo, and in the second, a nocebo.

A third problem is that the prescriber does not know whether the relevant subjects consider the effects that they experience to be subjectively desirable or undesirable until some time after the drugs have actually been administered.

A fourth problem is that, in cases such as this, precisely the same phenomena are being generated in all of the subjects, and these are being generated by precisely the same drug, which is acting in all of the subjects through precisely the same mechanism. Yet, just because the phenomena in question have been subjectively considered to be desirable to one group, but not the other, the phenomena are now being labelled in two mutually exclusive ways (i.e., placebo and nocebo); and this is giving the false impression that the drug in question has produced two entirely different phenomena.

These sorts of argument produce a strong case that — despite the fact that, in some of its applications, the term "placebo" is used to denote something that pleases (compared with it denoting an inert sumulator) — the desirability (placeboic nature) or undesirability (noceboic nature) of the phenomena that have been manifested by a subject, after a drug has been administered, should never be part of the definition of what constitutes either "a placebo" or "a placebo response".

Ambiguity of anthropological usage

Some people maintain that belief kills (e.g., "voodoo death": Cannon (1942) describes a number of "voodoo deaths" from a variety of different cultures) and belief heals (e.g., faith healing).

A "self-willed" death (due to voodoo hex, evil eye, pointing the bone procedure,^[5] etc.) is an extreme form of a culture-specific syndrome or sociogenic illness, that produces a particular form of psychosomatic or psychophysiological disorder, which results in a psychogenic death.

There are many recorded instances of self-willed psychogenic death. For example, the death of Ananias, as recorded in Acts 5:1-6; see Ananias and Sapphira.

Rubel (1964) spoke of "culture bound" syndromes, which were those "from which members of a particular group claim to suffer and for which their culture provides an etiology, diagnosis, preventive measures, and regimens of healing” (p.268).

It is important to distinguish these "self-willed deaths" from other "self-imposed" sorts of death, such as:

• the "self-inflicted deaths" of suicide, voluntary euthanasia, or the refusal of life-extending treatment;
• the "heroic" "self-inflicted death" of a soldier who throws himself on a hand grenade to save his mates, or that of the Antarctic explorer Captain Lawrence Oates (“I am just going outside and may be some time”); or
• the "religious self-inflicted death"' of the self-immolating suttee, or the mors voluntaria religiosa (= "voluntary religious death") of the aged person, who religious elders have permitted to voluntarily, peacefully, and slowly die by fasting.

Certain anthropologists, such as Robert Hahn and Arthur Kleinman have extended the placebo/nocebo distinction into this realm in order to allow a distinction to be made between rituals, like faith healing, that are performed in order to heal, cure, or bring benefit (placebo rituals) and others, like "pointing the bone", that are performed in order to kill, injure or bring harm (nocebo rituals).

As the meaning of the two inter-related and opposing terms has extended, we now find anthropologists speaking, in various contexts, of nocebo or placebo (harmful or helpful) rituals:-

• that might entail nocebo or placebo (unpleasant or pleasant) procedures,
• about which subjects might have nocebo or placebo (harmful or beneficial) beliefs,
• that are delivered by operators that might have nocebo or placebo (pathogenic, disease-generating or salutogenic, health-promoting) expectations,
• that are delivered to subjects that might have nocebo or placebo (negative, fearful, despairing or positive, hopeful, confident) expectations about the ritual,
• which are delivered by operators who might have nocebo or placebo (malevolent or benevolent) intentions, in the hope that the rituals will generate nocebo or placebo (lethal, injurious, harmful or restorative, curative, healthy) outcomes;

and, that all of this depends upon the operator's overall beliefs in the harmful nature of the nocebo ritual or the beneficial nature of the placebo ritual.

Yet, it may become even more terminologically complex; for, as Hahn and Kleinman indicate, there can also be cases where there are paradoxical nocebo outcomes from placebo rituals (e.g. the TGN1412 drug trial [1] [2]), as well as paradoxical placebo outcomes from nocebo rituals (see also unintended consequences).

Writing from his extensive experience of treating cancer (including more than 1,000 melanoma cases) at Sydney Hospital, Milton (1973) warned of the impact of the delivery of a prognosis, and how many of his patients, upon receiving their prognosis, simply turned their face to the wall and died an extremely premature death: "... there is a small group of patients in whom the realisation of impending death is a blow so terrible that they are quite unable to adjust to it, and they die rapidly before the malignancy seems to have developed enough to cause death. This problem of self-willed death is in some ways analogous to the death produced in primitive peoples by witchcraft (“Pointing the bone”)." (p.1435)

See also

Notes

1. ^ Miller (2003)
2. ^ McGlashan, Evans & Orne (1969); Stam (1984); Stam & Spanos (1987).
3. ^ ^{a b c} Kennedy (1961), p.204
4. ^ Stewart-Williams & Podd (2004), p.326
5. ^ Zusne & Jones (1989), p.57; Róheim (1925).

References

• Barber, T.X., "Death by Suggestion: A Critical Note", Psychosomatic Medicine, Vol.23, No.2, (March-April 1961), pp.153-155.
• Barker, J.C., Scared to Death: An Examination of Fear, its Cause and Effects, Frederick Muller, (London), 1968.
• Barrett, G.V. & Franke, R.H., ""Psychogenic" Death: A Reappraisal", Science, Vol.167, No.3916, (16 January 1970), pp.304-306.
• Barsky, A.J., Saintfort, R., Rogers, M.P. & Borus, J.F., "Nonspecific Medication Side Effects and the Nocebo Phenomenon", Journal of the American Medical Association, Vol.287, No.5, (6 February 2002), pp.622-627.
• Cannon, W.B., "“Voodoo” Death", American Anthropologist, Vol.44, No.2, (April-June 1942), pp.169-181.
• Charcot, J.M., "The Faith-Cure", The New Review, Vol.VIII, (January 1893), pp.18-31.
• Cohen, S.I., "Psychosomatic Death: Voodoo Death in a Modern Perspective", Integrative Psychiatry, Vol.3, No.1, (March 1985), pp.46-51.
• Dein, S., "Psychogenic Death: Individual Effects of Sorcery and Taboo Violation", Mental Health, Religion and Culture, Vol.6, No.3, (November 2003), pp.195-202.
• Di Blasi, Z., Harkness, E., Edzard, E., Georgiou, A. & Kleijnen, J., "Influence of Context Effects on Health Outcomes: A Systematic Review", The Lancet, Vol.357, No.9258, (10 March 2001), pp.757-762.
• Goddard, H.H., "The Effects of Mind on Body as Evidenced by Faith Cures", American Journal of Psychology, Vol.10, No.3, (April 1899), pp.431-502.
• Hahn, R.A., "The Nocebo Phenomenon: Concept, Evidence, and Implications for Public Health", Preventive Medicine, Vol.26, No.5, (September 1997), pp.607-611.
• Hahn, R.A. & Kleinman, A, "Belief as Pathogen, Belief as Medicine: "Voodoo Death" and the "Placebo Phenomenon" in Anthropological Perspective", Medical Anthropology Quarterly, Vol.14, No.4, (August 1983), pp.3, 16-19.
• Harrington, E.R., The Nocebo Effect: A Meta-Analysis of the Effect of Suggestion on Reports of Physical Symptoms, (Ph.D. Dissertation), Temple University, 1998.
• Houston, W.R., "The Doctor Himself as a Therapeutic Agent", Annals of Internal Medicine, Vol.11, No.8, (February 1938), pp.1416-1425.
• Kennedy, W P., "The Nocebo Reaction", Medical World, Vol.95, (September 1961), pp.203-205.
• Kirsch, I., "Response Expectancy as a Determinant of Experience and Behavior", American Psychologist, Vol.40, No.11, (November 1985), pp.1189-1202.
• Kirsch, I., "Response Expectancy Theory and Application: A Decennial Review", Applied and Preventive Psychology, Vol.6, No.2, (Spring 1997), pp.69-79.
• Lasagna, L., Mosteller, F., von Felsinger, J.M. & Beecher, H.K., "A Study of the Placebo Response", American Journal of Medicine, Vol.16, No.6, (June 1954), pp.770-779.
• Lorenz, J., Hauck, M., Paura, R.C., Nakamura, Y., Zimmermann, R., Bromm, B. & Engela, A.K., "Cortical Correlates of False Expectations During Pain Intensity Judgments — A Possible Manifestation of Placebo/Nocebo Cognitions", Brain, Behavior, and Immunity, Vol.19, No.4, (July 2005), pp.283-295.
• McGlashan, T.H., Evans, F.J. & Orne, M.T., "The Nature of Hypnotic Analgesia and Placebo Response to Experimental Pain", Psychosomatic Medicine, Vol.31, No.3, (May-June 1969), pp.227-246.
• Merton, R.K., "The Unanticipated Consequences of Purposive Social Action", American Sociological Review, Vol.1, No.6, (December 1936), pp.894-904. [3]
• Miller, F.G., "William James, Faith, and the Placebo Effect", Perspectives in Biology and Medicine, Vol.48, No.2, (Spring 2005), pp.273-281.
• Miller, F.G., "Sham Surgery: An Ethical Analysis", The American Journal of Bioethics, Vol.3, No.4, (Fall 2003), pp.41-48.
• Milton, G.W., "Self-Willed Death or the Bone-Pointing Syndrome", The Lancet, (23 June, 1973), pp.1435–1436.
• Perlman, L, "Nonspecific, Unintended, and Serendipitous Effects in Psychotherapy", Professional Psychology: Research and Practice, Vol.32, No.3, (June 2001), pp.283–288.
• Phillips, D.P., Liu, G.C., Kwok, K., Jarvinen, J.R., Zhang, W. & Abramson, I.S., "The Hound of the Baskervilles effect: natural experiment on the influence of psychological stress on timing of death", British Medical Journal, Vol.324, No.7327, (22-29 December 2001), pp.1443-1446.
• Pyysiäinen, I., "Mind and Miracles", Zygon, Vol.37, No.3, (September 2002), pp.729-740.
• Rief, W., Avorn, J. & Barsky, Arthur J., "Medication-Attributed Adverse Effects in Placebo Groups: Implications for Assessment of Adverse Effects", Archives of Internal Medicine, Vol.166, No.2), (23 January 2006), pp.155-160.
• Richter, C.P., "On the Phenomenon of Sudden Death in Animals and Man", Psychosomatic Medicine, Vol.XIX, No.3, (May-June 1957), pp.191–198.
• Róheim, G., "The Pointing Bone", The Journal of the Royal Anthropological Institute of Great Britain and Ireland, Vol.55, (January-June 1925), pp.90-114.
• Rubel, A.J., "The Epidemiology of a Folk Illness: Susto in Hispanic America", Ethnology, Vol.3, No.3, (July 1964), pp.268-283.
• Shapiro, A.K., "A Contribution to a History of the Placebo Effect", Behavioral Science, Vol.5, No.2 (April 1960) pp.109-135.
• Shapiro, A.K., "Semantics of the Placebo", Psychiatric Quarterly, Vol.42, No.4, (December 1968), pp.653–695.
• South, R., "A Sermon Delivered at Christ-Church, Oxon., Before the University, Octob. 14. 1688: Prov.XII.22 Lying Lips are abomination to the Lord", pp.519-657 in South, R., Twelve Sermons Preached Upon Several Occasions (Second Edition), Volume I, Printed by S.D. for Thomas Bennet, (London), 1697.
• Spiegel, H., "Nocebo: The Power of Suggestibility", Preventive Medicine, Vol.26, No.5, (1 September 1997), pp.616-621.
• Staats, P., Hekmatb, H. & Staats, A., "Suggestion/Placebo Effects on Pain: Negative as Well as Positive", Journal of Pain and Symptom Management, Vol.15, No.4, (April 1998), pp.235-243.
• Stam, H.J., Hypnotic Analgesia and the Placebo Effect: Controlling Ischemic Pain, (Ph.D. Dissertation), Carleton University, (Ottawa, Canada), 1984.
• Stam, H.J. & Spanos, N., "Hypnotic Analgesia, Placebo Analgesia, and Ischemic Pain: The Effects of Contextual Variables", Journal of Abnormal Psychology, Vol.96, No.4, (November 1987), pp.313–320.
• Stewart-Williams, S. & Podd, J., "The Placebo Effect: Dissolving the Expectancy Versus Conditioning Debate", Psychological Bulletin, Vol.130, No.2, (March 2004), pp.324-340.
• Wilson, I., The Bleeding Mind: An Investigation into the Mysterious Phenomenon of Stigmata, Paladin, (London), 1991.
• Zusne, L. & Jones, W.H., Anomalistic Psychology: A Study of Magical Thinking (Second Edition), Lawrence Erlbaum Associates, (New York), 1989.